| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Camelus | 22 | 2020 | 1425 | 4.26 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 33 | 2021 | 8843 | 2.71 | Why? |
| Zoonoses | 13 | 2021 | 3034 | 1.85 | Why? |
| Influenza, Human | 30 | 2021 | 10779 | 1.29 | Why? |
| Viral Tropism | 9 | 2021 | 1329 | 1.19 | Why? |
| Respiratory System | 11 | 2020 | 3213 | 1.13 | Why? |
| Influenza A Virus, H7N9 Subtype | 6 | 2019 | 415 | 1.12 | Why? |
| SARS Virus | 40 | 2020 | 13021 | 1.10 | Why? |
| Hong Kong | 27 | 2021 | 3361 | 1.07 | Why? |
| Disease Reservoirs | 7 | 2019 | 1672 | 1.02 | Why? |
| Severe Acute Respiratory Syndrome | 36 | 2020 | 12361 | 0.91 | Why? |
| Animals | 77 | 2021 | 78931 | 0.83 | Why? |
| Abattoirs | 3 | 2019 | 94 | 0.80 | Why? |
| Neuraminidase | 2 | 2019 | 289 | 0.78 | Why? |
| Toll-Like Receptor 10 | 2 | 2018 | 10 | 0.78 | Why? |
| Influenza A Virus, H2N2 Subtype | 1 | 2018 | 6 | 0.77 | Why? |
| Influenza A Virus, H3N2 Subtype | 5 | 2020 | 572 | 0.76 | Why? |
| Neutralization Tests | 13 | 2021 | 6698 | 0.75 | Why? |
| Influenza A virus | 8 | 2021 | 2234 | 0.71 | Why? |
| Antibodies, Viral | 38 | 2021 | 51949 | 0.70 | Why? |
| Coronavirus Infections | 56 | 2020 | 253789 | 0.69 | Why? |
| Orthomyxoviridae Infections | 5 | 2021 | 1001 | 0.69 | Why? |
| Horse Diseases | 1 | 2018 | 101 | 0.69 | Why? |
| Influenza A Virus, H5N1 Subtype | 5 | 2018 | 492 | 0.68 | Why? |
| Influenza in Birds | 7 | 2018 | 528 | 0.64 | Why? |
| West Nile Fever | 1 | 2018 | 166 | 0.63 | Why? |
| RNA, Double-Stranded | 1 | 2018 | 226 | 0.62 | Why? |
| Virus Replication | 16 | 2021 | 14331 | 0.60 | Why? |
| Toll-Like Receptor 3 | 1 | 2018 | 391 | 0.58 | Why? |
| Immune Sera | 2 | 2021 | 884 | 0.57 | Why? |
| Antibody Formation | 6 | 2020 | 4038 | 0.56 | Why? |
| Genetic Variation | 3 | 2019 | 3919 | 0.56 | Why? |
| Influenza B virus | 5 | 2020 | 815 | 0.54 | Why? |
| Enzyme-Linked Immunosorbent Assay | 15 | 2020 | 7868 | 0.53 | Why? |
| Dog Diseases | 1 | 2020 | 745 | 0.51 | Why? |
| Influenza A Virus, H9N2 Subtype | 3 | 2018 | 61 | 0.51 | Why? |
| Seroepidemiologic Studies | 9 | 2020 | 10017 | 0.51 | Why? |
| Influenza A Virus, H1N1 Subtype | 6 | 2020 | 2984 | 0.50 | Why? |
| Bronchi | 7 | 2020 | 1048 | 0.49 | Why? |
| Influenza Vaccines | 7 | 2020 | 2941 | 0.48 | Why? |
| Recombination, Genetic | 1 | 2019 | 1265 | 0.48 | Why? |
| Coronavirus | 11 | 2020 | 18339 | 0.47 | Why? |
| Saudi Arabia | 10 | 2019 | 4423 | 0.46 | Why? |
| Swine Diseases | 2 | 2018 | 1219 | 0.45 | Why? |
| Cross Reactions | 7 | 2021 | 4374 | 0.42 | Why? |
| Viral Envelope Proteins | 7 | 2011 | 3539 | 0.40 | Why? |
| Receptors, IgG | 2 | 2011 | 578 | 0.40 | Why? |
| Membrane Glycoproteins | 5 | 2011 | 2273 | 0.39 | Why? |
| Antibodies, Neutralizing | 16 | 2021 | 25288 | 0.39 | Why? |
| Phylogeny | 14 | 2021 | 13341 | 0.39 | Why? |
| Coronaviridae Infections | 1 | 2013 | 442 | 0.38 | Why? |
| Viral Proteins | 6 | 2020 | 7370 | 0.38 | Why? |
| Morocco | 3 | 2019 | 449 | 0.36 | Why? |
| Betacoronavirus | 19 | 2020 | 204454 | 0.36 | Why? |
| Nose | 3 | 2020 | 1093 | 0.35 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2020 | 13720 | 0.35 | Why? |
| RNA, Viral | 16 | 2020 | 32276 | 0.34 | Why? |
| Interferons | 2 | 2018 | 2885 | 0.34 | Why? |
| Nigeria | 4 | 2020 | 2292 | 0.34 | Why? |
| Antibody-Dependent Enhancement | 1 | 2011 | 413 | 0.34 | Why? |
| Serologic Tests | 4 | 2020 | 4359 | 0.33 | Why? |
| Humans | 133 | 2022 | 930598 | 0.33 | Why? |
| Coronaviridae | 1 | 2013 | 923 | 0.33 | Why? |
| Polymerase Chain Reaction | 5 | 2017 | 6740 | 0.33 | Why? |
| Dogs | 5 | 2021 | 2529 | 0.32 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2018 | 511 | 0.31 | Why? |
| Occupational Exposure | 3 | 2020 | 4742 | 0.31 | Why? |
| DNA, Protozoan | 1 | 2005 | 77 | 0.31 | Why? |
| Cats | 3 | 2021 | 1890 | 0.30 | Why? |
| Carboxypeptidases | 1 | 2005 | 148 | 0.30 | Why? |
| Respiratory Tract Infections | 5 | 2020 | 6817 | 0.29 | Why? |
| Conjunctiva | 2 | 2020 | 620 | 0.27 | Why? |
| Infection Control, Dental | 1 | 2004 | 64 | 0.27 | Why? |
| Chickens | 4 | 2017 | 1010 | 0.27 | Why? |
| Ethiopia | 2 | 2019 | 1222 | 0.26 | Why? |
| Viral Load | 8 | 2020 | 15850 | 0.26 | Why? |
| Molecular Sequence Data | 9 | 2017 | 3198 | 0.26 | Why? |
| Pneumonia, Viral | 20 | 2020 | 243684 | 0.26 | Why? |
| Chiroptera | 4 | 2020 | 3530 | 0.26 | Why? |
| Disease Outbreaks | 13 | 2021 | 27595 | 0.25 | Why? |
| Vero Cells | 13 | 2021 | 14117 | 0.24 | Why? |
| Organoids | 2 | 2019 | 840 | 0.24 | Why? |
| Lung | 14 | 2021 | 31049 | 0.24 | Why? |
| Africa | 3 | 2021 | 2986 | 0.23 | Why? |
| Arabia | 1 | 2021 | 36 | 0.23 | Why? |
| Plasmodium falciparum | 1 | 2005 | 337 | 0.23 | Why? |
| Ferrets | 5 | 2018 | 1201 | 0.23 | Why? |
| Mice, Inbred BALB C | 7 | 2021 | 5814 | 0.23 | Why? |
| Pulmonary Alveoli | 3 | 2006 | 867 | 0.23 | Why? |
| Gene Knock-In Techniques | 1 | 2021 | 124 | 0.23 | Why? |
| Malaria, Falciparum | 1 | 2005 | 377 | 0.22 | Why? |
| Fitness Centers | 1 | 2021 | 65 | 0.22 | Why? |
| Male | 50 | 2021 | 367725 | 0.21 | Why? |
| Sf9 Cells | 4 | 2021 | 273 | 0.21 | Why? |
| Emetine | 1 | 2020 | 70 | 0.20 | Why? |
| Horses | 2 | 2019 | 474 | 0.20 | Why? |
| Spike Glycoprotein, Coronavirus | 12 | 2021 | 37182 | 0.20 | Why? |
| Female | 49 | 2021 | 380317 | 0.20 | Why? |
| Genotype | 5 | 2021 | 4697 | 0.20 | Why? |
| Antimetabolites | 1 | 2020 | 106 | 0.20 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.20 | Why? |
| Disease Models, Animal | 8 | 2020 | 10998 | 0.20 | Why? |
| Virus Shedding | 5 | 2020 | 5834 | 0.20 | Why? |
| Pandemics | 24 | 2021 | 389249 | 0.19 | Why? |
| History, 21st Century | 4 | 2021 | 1849 | 0.19 | Why? |
| Poultry | 2 | 2017 | 437 | 0.19 | Why? |
| Genome, Viral | 6 | 2021 | 13157 | 0.18 | Why? |
| Egypt | 4 | 2019 | 1211 | 0.18 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.18 | Why? |
| Immunization, Passive | 1 | 2015 | 10067 | 0.18 | Why? |
| Influenza A Virus, H5N8 Subtype | 1 | 2018 | 50 | 0.18 | Why? |
| Sequence Analysis, RNA | 2 | 2019 | 2290 | 0.18 | Why? |
| Culex | 1 | 2018 | 66 | 0.18 | Why? |
| Tupaiidae | 1 | 2018 | 58 | 0.18 | Why? |
| Lymphocytes | 1 | 2011 | 3056 | 0.18 | Why? |
| Organ Culture Techniques | 2 | 2019 | 119 | 0.17 | Why? |
| Sensitivity and Specificity | 12 | 2021 | 22971 | 0.17 | Why? |
| Hot Temperature | 1 | 2005 | 1299 | 0.17 | Why? |
| Orthomyxoviridae | 4 | 2020 | 1168 | 0.17 | Why? |
| Drug Utilization Review | 1 | 2018 | 72 | 0.17 | Why? |
| Trachea | 2 | 2021 | 894 | 0.17 | Why? |
| Hydrocephalus | 1 | 2018 | 139 | 0.17 | Why? |
| Immunity, Innate | 7 | 2020 | 6570 | 0.17 | Why? |
| Air | 1 | 2018 | 145 | 0.17 | Why? |
| West Nile virus | 1 | 2018 | 206 | 0.17 | Why? |
| THP-1 Cells | 1 | 2018 | 374 | 0.16 | Why? |
| Pets | 1 | 2020 | 314 | 0.16 | Why? |
| Serum | 1 | 2019 | 294 | 0.16 | Why? |
| Animals, Domestic | 1 | 2019 | 272 | 0.16 | Why? |
| Epithelial Cells | 5 | 2022 | 3508 | 0.16 | Why? |
| Lysine | 1 | 2017 | 153 | 0.16 | Why? |
| Nasal Cavity | 2 | 2021 | 909 | 0.16 | Why? |
| Poultry Diseases | 2 | 2017 | 588 | 0.16 | Why? |
| Cross Protection | 1 | 2019 | 373 | 0.16 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.16 | Why? |
| Middle Aged | 29 | 2021 | 270681 | 0.16 | Why? |
| Adolescent | 19 | 2021 | 86841 | 0.16 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4545 | 0.16 | Why? |
| Burkina Faso | 1 | 2017 | 302 | 0.16 | Why? |
| Nucleocapsid Proteins | 6 | 2006 | 3120 | 0.16 | Why? |
| Immunologic Memory | 2 | 2019 | 3362 | 0.16 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.16 | Why? |
| Mongolia | 1 | 2015 | 33 | 0.15 | Why? |
| Kazakhstan | 1 | 2016 | 132 | 0.15 | Why? |
| Molecular Epidemiology | 2 | 2015 | 1638 | 0.15 | Why? |
| Kinetics | 3 | 2021 | 3238 | 0.15 | Why? |
| Rabbits | 1 | 2019 | 1171 | 0.15 | Why? |
| Terminology as Topic | 1 | 2021 | 546 | 0.15 | Why? |
| N-Acetylneuraminic Acid | 1 | 2017 | 198 | 0.15 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.15 | Why? |
| Mosquito Vectors | 1 | 2018 | 351 | 0.15 | Why? |
| Cells, Cultured | 7 | 2019 | 5835 | 0.14 | Why? |
| Open Reading Frames | 3 | 2019 | 1898 | 0.14 | Why? |
| Camelids, New World | 1 | 2016 | 276 | 0.14 | Why? |
| Child, Preschool | 12 | 2021 | 36283 | 0.14 | Why? |
| Aspartic Acid | 1 | 2014 | 76 | 0.14 | Why? |
| Mutation, Missense | 2 | 2018 | 863 | 0.14 | Why? |
| Adult | 29 | 2021 | 244371 | 0.14 | Why? |
| Mesocricetus | 1 | 2020 | 1847 | 0.14 | Why? |
| Endosomes | 1 | 2018 | 490 | 0.14 | Why? |
| Meat | 1 | 2017 | 380 | 0.14 | Why? |
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3633 | 0.14 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.14 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2021 | 1061 | 0.13 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.13 | Why? |
| Real-Time Polymerase Chain Reaction | 8 | 2020 | 11367 | 0.13 | Why? |
| Rectum | 1 | 2017 | 495 | 0.13 | Why? |
| Middle East | 2 | 2019 | 1418 | 0.13 | Why? |
| Infant | 9 | 2021 | 30274 | 0.13 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.13 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.13 | Why? |
| Encephalitis, Viral | 1 | 2018 | 355 | 0.13 | Why? |
| Cell Adhesion Molecules | 2 | 2007 | 472 | 0.13 | Why? |
| Swine | 3 | 2018 | 3352 | 0.13 | Why? |
| Pharynx | 2 | 2020 | 1544 | 0.13 | Why? |
| China | 13 | 2021 | 50654 | 0.13 | Why? |
| Longitudinal Studies | 5 | 2021 | 9893 | 0.12 | Why? |
| Vietnam | 1 | 2018 | 1665 | 0.12 | Why? |
| Epidemics | 4 | 2021 | 6407 | 0.12 | Why? |
| Iatrogenic Disease | 1 | 2015 | 304 | 0.12 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Public Health Surveillance | 4 | 2018 | 3129 | 0.12 | Why? |
| Virus Internalization | 1 | 2011 | 7921 | 0.12 | Why? |
| Dendritic Cells | 3 | 2020 | 1330 | 0.12 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2021 | 3607 | 0.12 | Why? |
| Environmental Microbiology | 1 | 2017 | 575 | 0.12 | Why? |
| Genetic Predisposition to Disease | 5 | 2007 | 4027 | 0.12 | Why? |
| Receptors, Virus | 3 | 2020 | 5659 | 0.12 | Why? |
| Fatal Outcome | 2 | 2017 | 3438 | 0.12 | Why? |
| Down-Regulation | 2 | 2010 | 1416 | 0.11 | Why? |
| Proteasome Endopeptidase Complex | 2 | 2010 | 249 | 0.11 | Why? |
| Aged | 23 | 2021 | 215776 | 0.11 | Why? |
| Antigens, Viral | 5 | 2020 | 6298 | 0.11 | Why? |
| Demography | 1 | 2018 | 1660 | 0.11 | Why? |
| Interferon-alpha | 2 | 2018 | 1442 | 0.11 | Why? |
| Cysteine Proteases | 1 | 2011 | 84 | 0.11 | Why? |
| Amino Acid Substitution | 2 | 2018 | 1706 | 0.11 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.11 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2005 | 3388 | 0.11 | Why? |
| Endocytosis | 1 | 2014 | 451 | 0.11 | Why? |
| Amino Acid Sequence | 4 | 2017 | 6049 | 0.11 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.11 | Why? |
| Nucleoside-Phosphate Kinase | 1 | 2010 | 55 | 0.11 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.11 | Why? |
| Immunity | 2 | 2020 | 2651 | 0.10 | Why? |
| New York | 1 | 2018 | 2488 | 0.10 | Why? |
| Receptors, CCR3 | 1 | 2009 | 7 | 0.10 | Why? |
| Mice | 7 | 2021 | 21357 | 0.10 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.10 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.10 | Why? |
| Child | 13 | 2021 | 70012 | 0.10 | Why? |
| Geography | 1 | 2016 | 1801 | 0.10 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 47 | 0.10 | Why? |
| Receptors, CCR1 | 1 | 2009 | 49 | 0.10 | Why? |
| Chemokine CCL5 | 2 | 2007 | 169 | 0.10 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.10 | Why? |
| Tight Junctions | 1 | 2010 | 179 | 0.10 | Why? |
| Microscopy, Fluorescence | 4 | 2014 | 335 | 0.09 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.09 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.09 | Why? |
| Goats | 2 | 2019 | 217 | 0.09 | Why? |
| Specimen Handling | 1 | 2005 | 6190 | 0.09 | Why? |
| Caveolin 1 | 1 | 2007 | 73 | 0.09 | Why? |
| Infectious Disease Incubation Period | 1 | 2015 | 1033 | 0.09 | Why? |
| Exercise | 1 | 2008 | 6771 | 0.09 | Why? |
| Receptors, CCR5 | 1 | 2009 | 186 | 0.09 | Why? |
| Birds | 3 | 2018 | 412 | 0.08 | Why? |
| Hydrogen-Ion Concentration | 1 | 2011 | 993 | 0.08 | Why? |
| Communicable Diseases, Emerging | 2 | 2021 | 2523 | 0.08 | Why? |
| Evolution, Molecular | 2 | 2019 | 3691 | 0.08 | Why? |
| Poisson Distribution | 1 | 2008 | 348 | 0.08 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.08 | Why? |
| Sheep | 2 | 2019 | 420 | 0.08 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Time Factors | 9 | 2020 | 31397 | 0.08 | Why? |
| Alveolar Epithelial Cells | 3 | 2020 | 1445 | 0.08 | Why? |
| Population Surveillance | 4 | 2019 | 4967 | 0.08 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.08 | Why? |
| Reproducibility of Results | 5 | 2021 | 11304 | 0.08 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.07 | Why? |
| Smoking | 1 | 2019 | 3358 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Chemokines | 2 | 2017 | 1095 | 0.07 | Why? |
| Base Sequence | 4 | 2006 | 3581 | 0.07 | Why? |
| Calibration | 1 | 2005 | 307 | 0.07 | Why? |
| Signal Transduction | 2 | 2020 | 7207 | 0.07 | Why? |
| Mannose-Binding Lectin | 1 | 2005 | 131 | 0.07 | Why? |
| Histological Techniques | 1 | 2003 | 35 | 0.07 | Why? |
| Coronavirus 229E, Human | 1 | 2013 | 1241 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| Nucleoside-Triphosphatase | 1 | 2003 | 18 | 0.07 | Why? |
| Metaplasia | 1 | 2003 | 43 | 0.07 | Why? |
| Chromatography | 1 | 2004 | 112 | 0.07 | Why? |
| Viral Structural Proteins | 1 | 2007 | 491 | 0.07 | Why? |
| Cattle | 2 | 2019 | 1336 | 0.06 | Why? |
| Aged, 80 and over | 9 | 2020 | 88759 | 0.06 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.06 | Why? |
| Leukocytes, Mononuclear | 3 | 2020 | 2115 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.06 | Why? |
| Lectins, C-Type | 1 | 2005 | 405 | 0.06 | Why? |
| Immunologic Tests | 1 | 2005 | 445 | 0.06 | Why? |
| DNA Helicases | 1 | 2003 | 203 | 0.06 | Why? |
| Recombinant Proteins | 4 | 2005 | 3786 | 0.06 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.06 | Why? |
| Organ Size | 1 | 2003 | 384 | 0.06 | Why? |
| Macrophages | 1 | 2014 | 2784 | 0.06 | Why? |
| Sequence Deletion | 1 | 2006 | 674 | 0.06 | Why? |
| Macaca fascicularis | 2 | 2003 | 1009 | 0.06 | Why? |
| Antiviral Agents | 4 | 2020 | 41703 | 0.06 | Why? |
| Antigens, CD | 1 | 2007 | 984 | 0.06 | Why? |
| Models, Biological | 1 | 2019 | 4907 | 0.06 | Why? |
| Receptors, Cell Surface | 1 | 2005 | 586 | 0.06 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.06 | Why? |
| Risk Assessment | 4 | 2019 | 25439 | 0.05 | Why? |
| Hospitalization | 5 | 2019 | 54280 | 0.05 | Why? |
| Housing, Animal | 1 | 2020 | 53 | 0.05 | Why? |
| Protein Binding | 5 | 2021 | 11430 | 0.05 | Why? |
| Giant Cells | 1 | 2003 | 334 | 0.05 | Why? |
| Gene Frequency | 2 | 2021 | 1210 | 0.05 | Why? |
| Hemagglutination | 1 | 2020 | 36 | 0.05 | Why? |
| Cell Nucleus | 1 | 2003 | 399 | 0.05 | Why? |
| Regression Analysis | 1 | 2008 | 2484 | 0.05 | Why? |
| Cytokines | 6 | 2020 | 15010 | 0.05 | Why? |
| Prevalence | 3 | 2018 | 25773 | 0.05 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.05 | Why? |
| Single-Cell Analysis | 2 | 2021 | 2450 | 0.05 | Why? |
| RNA Helicases | 1 | 2003 | 413 | 0.05 | Why? |
| Membrane Proteins | 1 | 2010 | 1733 | 0.05 | Why? |
| Endothelial Cells | 2 | 2022 | 2048 | 0.05 | Why? |
| Turkeys | 1 | 2019 | 65 | 0.05 | Why? |
| Polymorphism, Genetic | 1 | 2007 | 1074 | 0.05 | Why? |
| World Health Organization | 2 | 2021 | 4213 | 0.05 | Why? |
| Cell Communication | 1 | 2022 | 396 | 0.05 | Why? |
| Two-Hybrid System Techniques | 2 | 2010 | 116 | 0.05 | Why? |
| Duodenum | 1 | 2020 | 179 | 0.05 | Why? |
| Tropism | 1 | 2020 | 210 | 0.05 | Why? |
| Nucleocapsid | 1 | 2004 | 734 | 0.05 | Why? |
| Odds Ratio | 2 | 2008 | 5861 | 0.05 | Why? |
| L-Lactate Dehydrogenase | 1 | 2007 | 1995 | 0.05 | Why? |
| CHO Cells | 2 | 2014 | 831 | 0.04 | Why? |
| Hemagglutinins | 1 | 2019 | 143 | 0.04 | Why? |
| Senegal | 1 | 2019 | 283 | 0.04 | Why? |
| Mice, SCID | 1 | 2018 | 225 | 0.04 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.04 | Why? |
| Antigens | 1 | 2020 | 267 | 0.04 | Why? |
| DNA Replication | 1 | 2018 | 121 | 0.04 | Why? |
| Cricetulus | 2 | 2014 | 936 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2020 | 563 | 0.04 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2020 | 385 | 0.04 | Why? |
| Systems Biology | 1 | 2020 | 320 | 0.04 | Why? |
| Commerce | 2 | 2017 | 1109 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2019 | 640 | 0.04 | Why? |
| Haplotypes | 1 | 2021 | 853 | 0.04 | Why? |
| Air Conditioning | 1 | 2019 | 215 | 0.04 | Why? |
| Boston | 1 | 2020 | 929 | 0.04 | Why? |
| Ducks | 1 | 2017 | 120 | 0.04 | Why? |
| Tunisia | 1 | 2019 | 543 | 0.04 | Why? |
| Up-Regulation | 1 | 2005 | 2249 | 0.04 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.04 | Why? |
| Travel | 1 | 2015 | 7220 | 0.04 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.04 | Why? |
| Monocytes | 2 | 2009 | 2978 | 0.04 | Why? |
| Immunohistochemistry | 2 | 2019 | 2275 | 0.04 | Why? |
| Tissue Culture Techniques | 1 | 2017 | 158 | 0.04 | Why? |
| Vaccine Potency | 1 | 2018 | 339 | 0.04 | Why? |
| Virulence | 2 | 2017 | 2172 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2019 | 907 | 0.04 | Why? |
| Exhalation | 1 | 2020 | 441 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2016 | 4260 | 0.04 | Why? |
| Cerebrospinal Fluid | 1 | 2018 | 234 | 0.04 | Why? |
| DNA, Bacterial | 1 | 2020 | 835 | 0.04 | Why? |
| Flow Cytometry | 2 | 2020 | 2393 | 0.04 | Why? |
| Mandatory Reporting | 1 | 2017 | 140 | 0.04 | Why? |
| Vaccination | 2 | 2020 | 19050 | 0.04 | Why? |
| Lipopolysaccharides | 1 | 2020 | 848 | 0.04 | Why? |
| Respiratory Mucosa | 2 | 2020 | 1522 | 0.04 | Why? |
| Virus Release | 1 | 2017 | 253 | 0.04 | Why? |
| Reassortant Viruses | 1 | 2017 | 287 | 0.04 | Why? |
| Life Style | 1 | 2008 | 2708 | 0.04 | Why? |
| Myeloid Cells | 1 | 2020 | 808 | 0.04 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.04 | Why? |
| Reverse Transcription | 1 | 2018 | 673 | 0.04 | Why? |
| Nasopharynx | 3 | 2017 | 10224 | 0.03 | Why? |
| Universities | 2 | 2020 | 4374 | 0.03 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2020 | 1326 | 0.03 | Why? |
| Immunoglobulin G | 7 | 2019 | 21571 | 0.03 | Why? |
| Viverridae | 1 | 2014 | 225 | 0.03 | Why? |
| Biopsy | 1 | 2003 | 2811 | 0.03 | Why? |
| Occupations | 1 | 2019 | 733 | 0.03 | Why? |
| Fomites | 1 | 2020 | 709 | 0.03 | Why? |
| Aerosols | 2 | 2020 | 5393 | 0.03 | Why? |
| Erythrocytes | 1 | 2019 | 617 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2018 | 704 | 0.03 | Why? |
| Republic of Korea | 2 | 2017 | 5858 | 0.03 | Why? |
| Models, Theoretical | 1 | 2012 | 6659 | 0.03 | Why? |
| Lebanon | 1 | 2016 | 557 | 0.03 | Why? |
| Cell Differentiation | 1 | 2019 | 1338 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 2 | 2010 | 925 | 0.03 | Why? |
| Biomedical Research | 1 | 2013 | 5270 | 0.03 | Why? |
| Ribavirin | 1 | 2020 | 1182 | 0.03 | Why? |
| North America | 1 | 2017 | 1400 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.03 | Why? |
| Blotting, Western | 2 | 2005 | 863 | 0.03 | Why? |
| Bangladesh | 1 | 2018 | 1620 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2020 | 1649 | 0.03 | Why? |
| Housing | 1 | 2019 | 1146 | 0.03 | Why? |
| Fluorescent Antibody Technique | 2 | 2004 | 835 | 0.03 | Why? |
| Morphogenesis | 1 | 2010 | 43 | 0.03 | Why? |
| Glutathione Transferase | 1 | 2010 | 86 | 0.03 | Why? |
| Antibody Affinity | 1 | 2015 | 1078 | 0.03 | Why? |
| Luminescent Proteins | 1 | 2010 | 142 | 0.03 | Why? |
| Toll-Like Receptor 1 | 1 | 2009 | 6 | 0.03 | Why? |
| Immunoblotting | 1 | 2010 | 180 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2017 | 1093 | 0.02 | Why? |
| Gene Knockout Techniques | 1 | 2010 | 347 | 0.02 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Mutagenesis, Site-Directed | 1 | 2010 | 449 | 0.02 | Why? |
| Fas Ligand Protein | 1 | 2009 | 69 | 0.02 | Why? |
| Green Fluorescent Proteins | 1 | 2010 | 450 | 0.02 | Why? |
| Epitope Mapping | 1 | 2014 | 1240 | 0.02 | Why? |
| Ubiquitination | 1 | 2010 | 343 | 0.02 | Why? |
| Immunoglobulin A | 3 | 2006 | 3567 | 0.02 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2020 | 2654 | 0.02 | Why? |
| Comorbidity | 2 | 2016 | 34796 | 0.02 | Why? |
| HEK293 Cells | 2 | 2014 | 8394 | 0.02 | Why? |
| Amides | 1 | 2020 | 1864 | 0.02 | Why? |
| Ubiquitin | 1 | 2010 | 243 | 0.02 | Why? |
| Epithelium | 1 | 2010 | 330 | 0.02 | Why? |
| Air Microbiology | 1 | 2018 | 1322 | 0.02 | Why? |
| Sequence Alignment | 1 | 2014 | 2109 | 0.02 | Why? |
| Protein Stability | 1 | 2010 | 756 | 0.02 | Why? |
| Golgi Apparatus | 1 | 2007 | 178 | 0.02 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.02 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.02 | Why? |
| Logistic Models | 2 | 2015 | 9089 | 0.02 | Why? |
| Gene Order | 1 | 2006 | 144 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2019 | 53120 | 0.02 | Why? |
| Tandem Repeat Sequences | 1 | 2005 | 78 | 0.02 | Why? |
| Immune Evasion | 1 | 2017 | 2081 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.02 | Why? |
| Macrophage Inflammatory Proteins | 1 | 2005 | 14 | 0.02 | Why? |
| Age Distribution | 2 | 2007 | 3567 | 0.02 | Why? |
| Interleukin-12 Subunit p40 | 1 | 2005 | 26 | 0.02 | Why? |
| Virion | 1 | 2014 | 1444 | 0.02 | Why? |
| Bayes Theorem | 1 | 2015 | 3237 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Multigene Family | 1 | 2006 | 377 | 0.02 | Why? |
| Genes, pol | 1 | 2005 | 38 | 0.02 | Why? |
| Fetal Blood | 1 | 2009 | 573 | 0.02 | Why? |
| Recombinant Fusion Proteins | 1 | 2010 | 919 | 0.02 | Why? |
| Infant, Newborn | 2 | 2017 | 23105 | 0.02 | Why? |
| Chemokine CCL4 | 1 | 2005 | 71 | 0.02 | Why? |
| Protein Interaction Mapping | 1 | 2007 | 487 | 0.02 | Why? |
| Chemokine CCL3 | 1 | 2005 | 103 | 0.02 | Why? |
| Caspases | 1 | 2005 | 156 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Homozygote | 1 | 2005 | 230 | 0.02 | Why? |
| Caspase 3 | 1 | 2005 | 218 | 0.02 | Why? |
| Confidence Intervals | 1 | 2007 | 744 | 0.02 | Why? |
| Interleukin-12 | 1 | 2005 | 156 | 0.02 | Why? |
| In Situ Hybridization | 1 | 2006 | 390 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2020 | 4624 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.02 | Why? |
| Pneumonia | 1 | 2004 | 5652 | 0.02 | Why? |
| Serial Passage | 1 | 2003 | 126 | 0.02 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 393 | 0.02 | Why? |
| Enzyme Activation | 1 | 2005 | 425 | 0.02 | Why? |
| Sleep Stages | 1 | 2003 | 52 | 0.02 | Why? |
| Acute Disease | 1 | 2016 | 6029 | 0.02 | Why? |
| Urinary Tract | 1 | 2003 | 77 | 0.02 | Why? |
| Cell Separation | 1 | 2005 | 270 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Digestive System | 1 | 2003 | 110 | 0.02 | Why? |
| Autopsy | 2 | 2006 | 3495 | 0.02 | Why? |
| Probability | 1 | 2007 | 923 | 0.02 | Why? |
| Case-Control Studies | 3 | 2007 | 17671 | 0.02 | Why? |
| Microscopy, Electron, Transmission | 1 | 2005 | 605 | 0.02 | Why? |
| Immunity, Mucosal | 1 | 2006 | 426 | 0.02 | Why? |
| Chemokine CCL2 | 1 | 2005 | 389 | 0.02 | Why? |
| Intestine, Small | 1 | 2005 | 336 | 0.02 | Why? |
| Peptides | 2 | 2005 | 2513 | 0.02 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.01 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.01 | Why? |
| Carrier State | 1 | 2014 | 2100 | 0.01 | Why? |
| Protein Subunits | 1 | 2005 | 755 | 0.01 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.01 | Why? |
| Cross Infection | 1 | 2004 | 8675 | 0.01 | Why? |
| Prognosis | 3 | 2016 | 32490 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2004 | 9706 | 0.01 | Why? |
| Substrate Specificity | 1 | 2003 | 639 | 0.01 | Why? |
| Antibodies, Monoclonal | 2 | 2014 | 8041 | 0.01 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.01 | Why? |
| Genes, Viral | 1 | 2006 | 1428 | 0.01 | Why? |
| Analysis of Variance | 1 | 2004 | 950 | 0.01 | Why? |
| DNA Primers | 1 | 2005 | 1170 | 0.01 | Why? |
| Feces | 2 | 2005 | 4235 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Quality Assurance, Health Care | 1 | 2005 | 596 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Databases, Factual | 1 | 2015 | 6248 | 0.01 | Why? |
| Reference Standards | 1 | 2004 | 1163 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Sex Distribution | 1 | 2007 | 2083 | 0.01 | Why? |
| False Positive Reactions | 1 | 2004 | 1338 | 0.01 | Why? |
| Antibody Specificity | 1 | 2004 | 1328 | 0.01 | Why? |
| Interferon-beta | 1 | 2005 | 979 | 0.01 | Why? |
| Complement Activation | 1 | 2005 | 949 | 0.01 | Why? |
| Binding Sites | 1 | 2010 | 6201 | 0.01 | Why? |
| RNA | 1 | 2005 | 1278 | 0.01 | Why? |
| Leukocyte Count | 1 | 2007 | 3178 | 0.01 | Why? |
| United States | 1 | 2004 | 46150 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2006 | 3776 | 0.01 | Why? |
| Immunoglobulin M | 2 | 2004 | 9091 | 0.01 | Why? |
| Gene Expression Regulation | 1 | 2009 | 4020 | 0.01 | Why? |
| Radiography | 1 | 2004 | 1576 | 0.01 | Why? |
| Animals, Wild | 1 | 2003 | 1028 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2005 | 2830 | 0.01 | Why? |
| Interferon-gamma | 1 | 2005 | 2711 | 0.01 | Why? |
| Exanthema | 1 | 2003 | 1097 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| DNA, Viral | 1 | 2003 | 2521 | 0.01 | Why? |
| Retrospective Studies | 1 | 2004 | 105322 | 0.01 | Why? |
| Intensive Care Units | 1 | 2019 | 29594 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Liver | 1 | 2003 | 4007 | 0.01 | Why? |
| Interleukin-6 | 1 | 2005 | 7522 | 0.01 | Why? |
| Pregnancy | 1 | 2009 | 23879 | 0.00 | Why? |